kidney pain semaglutide Is Ozempic Safe for Your Kidneys? Ozempic and GLP-1 Drugs: Risk

Some patients also ask about stretching a prescription with lower doses, which saves money but has no trial support

At a median follow-up of 4.2 years, incidence of the composite endpoint of stroke, acute coronary syndrome, heart failure and cardiovascular death was lower in the intensive treatment group (HR 0.79, 95% CI 0.690.90), with no age-related interaction observed

The heterogeneity between subgroups was not significant (P = 0.127) suggesting that patients with or without a history of CVD behave as a whole population

2014, global cardiology science and practice

F.GiblinL

This content is for informational and educational purposes only and does not replace medical advice, diagnosis, or treatment